BioCentury | May 20, 2019
Company News

May 20 Company Quick Takes: LifeArc trades Keytruda royalties for $1.3B; plus Evotec-Just, Actelion-Owlstone, Genomind

...the indication. Genomind launches genetics-based mental health test Genomind Inc. (King of Prussia, Pa.) said its Genomind...
...implications of those genes to 130 FDA-approved medications. Sandi Wong, Staff Writer Keytruda, pembrolizumab (MK-3475, lambrolizumab) Actelion Ltd. Evotec AG Genomind Inc. Just...
BioCentury | Feb 10, 2017
Financial News

Genomind completes venture financing

...Mental health genetic testing company Genomind Inc. (King of Prussia, Pa.) raised $6 million in a series...
...$5 million from Silicon Valley Bank on Feb. 8. Genomind Inc. , King of Prussia, Pa. Alex Himes Genomind Inc....
BioCentury | May 5, 2014
Company News

Genomind management update

Genomind LLC , Chalfont, Pa. Business: Neurology Transitioned: Michael Koffler to president and CEO from CFO; he succeeds Scott Storrer, who became president and CEO of FirstLab WIR Staff...
BioCentury | Apr 14, 2014
Financial News

Genomind completes venture financing

Genomind LLC , Chalfont, Pa. Business: Neurology Date completed: 4/9/14 Type: Venture financing Raised: $5 million Investor: Claritas Capital WIR Staff Neurology...
BioCentury | Nov 11, 2013
Company News

Genomind, Emory University deal

...biomarkers from Emory to assess for risk of mild cognitive impairment and Alzheimer's disease (AD). Genomind...
BioCentury | Feb 27, 2012
Clinical News

Genecept Assay: Pilot trial started

...trial to use its Genecept Assay to evaluate assay-guided treatment in patients with treatment-resistant MDD. Genomind...
Items per page:
1 - 6 of 6
BioCentury | May 20, 2019
Company News

May 20 Company Quick Takes: LifeArc trades Keytruda royalties for $1.3B; plus Evotec-Just, Actelion-Owlstone, Genomind

...the indication. Genomind launches genetics-based mental health test Genomind Inc. (King of Prussia, Pa.) said its Genomind...
...implications of those genes to 130 FDA-approved medications. Sandi Wong, Staff Writer Keytruda, pembrolizumab (MK-3475, lambrolizumab) Actelion Ltd. Evotec AG Genomind Inc. Just...
BioCentury | Feb 10, 2017
Financial News

Genomind completes venture financing

...Mental health genetic testing company Genomind Inc. (King of Prussia, Pa.) raised $6 million in a series...
...$5 million from Silicon Valley Bank on Feb. 8. Genomind Inc. , King of Prussia, Pa. Alex Himes Genomind Inc....
BioCentury | May 5, 2014
Company News

Genomind management update

Genomind LLC , Chalfont, Pa. Business: Neurology Transitioned: Michael Koffler to president and CEO from CFO; he succeeds Scott Storrer, who became president and CEO of FirstLab WIR Staff...
BioCentury | Apr 14, 2014
Financial News

Genomind completes venture financing

Genomind LLC , Chalfont, Pa. Business: Neurology Date completed: 4/9/14 Type: Venture financing Raised: $5 million Investor: Claritas Capital WIR Staff Neurology...
BioCentury | Nov 11, 2013
Company News

Genomind, Emory University deal

...biomarkers from Emory to assess for risk of mild cognitive impairment and Alzheimer's disease (AD). Genomind...
BioCentury | Feb 27, 2012
Clinical News

Genecept Assay: Pilot trial started

...trial to use its Genecept Assay to evaluate assay-guided treatment in patients with treatment-resistant MDD. Genomind...
Items per page:
1 - 6 of 6